Featured Research

from universities, journals, and other organizations

Scientists Advocate Delaying Medication For Early Epilepsy

Date:
June 14, 2005
Source:
University of Liverpool
Summary:
Scientists investigating epilepsy at the University of Liverpool have found no significant long-term benefit in administering immediate treatment to those with early epilepsy and infrequent seizures.

Scientists investigating epilepsy at the University of Liverpool have found no significant long-term benefit in administering immediate treatment to those with early epilepsy and infrequent seizures.

Around 500,000 people in the UK suffer from epilepsy, making it the most common serious neurological condition. Many of those who develop epilepsy start having seizures during childhood, but it can develop at any age.

The risks and benefits of starting or withholding treatment for patients with few or infrequent seizures have always been unclear, but research now suggests that early treatment adds little if any benefit to a patient's quality of life.

Professor David Chadwick and his team, from the University's Division of Neuroscience, found that early treatment does not reduce their risk of seizure recurrence in the long-term and delaying medication does not increase their risk of chronic epilepsy.

The scientists, whose research is published in this week's issue of The Lancet, conducted a randomised trial of 1,400 patients with single or infrequent seizures from around the world. Half were assigned to immediate treatment with antiepileptic drugs and half were assigned to deferred treatment, where they received no drug until they and their clinician agreed treatment was necessary.

The trial found that immediate treatment reduced short-term seizure recurrence but had no effect on long-term outcomes. More patients in the immediate treatment group than in the deferred group experienced adverse effects that were probably treatment related. There was no difference in quality of life between the two groups.

Professor Chadwick said: "We have sought to quantify precisely benefits in terms of seizure control, to improve the quality of information available to support clinicians and patients in making decisions about treatment options. "We have shown that a policy of immediate treatment with antiepileptic drugs, mainly with carbamazepine or valproate, reduces the occurrence of seizures in the next one to two years, but does not modify rates of long-term remission after a first or after several seizures.

"After two years, the benefits of improved seizure control with immediate treatment seem to be balanced by the unwanted effects of drug treatment and there is no improvement in measures of quality of life."

Samuel Berkovic from the University of Melbourne, Australia, added: "Apart from a decreased risk of proximate seizures, the results of this study suggest there is little to gain in the long-term from starting medication immediately."

"In what is often a difficult decision good data coupled with a clinical synthesis of the risks and benefits that are tailored to the patient's personal circumstances will contribute to optimum treatment decisions."



Story Source:

The above story is based on materials provided by University of Liverpool. Note: Materials may be edited for content and length.


Cite This Page:

University of Liverpool. "Scientists Advocate Delaying Medication For Early Epilepsy." ScienceDaily. ScienceDaily, 14 June 2005. <www.sciencedaily.com/releases/2005/06/050612111442.htm>.
University of Liverpool. (2005, June 14). Scientists Advocate Delaying Medication For Early Epilepsy. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2005/06/050612111442.htm
University of Liverpool. "Scientists Advocate Delaying Medication For Early Epilepsy." ScienceDaily. www.sciencedaily.com/releases/2005/06/050612111442.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins